Global Neuroprosthetics Market - 2025 -2033
Market Overview
Neuroprosthetics Market is estimated to reach at a CAGR of 12.2% during the forecast period (2024-2031). Neuroprosthetics (neural prosthetics) is a branch of neuroscience and biomedical engineering concerned with developing neural prostheses. These are a series of devices that can substitute for the functions of a motor, sensory, or cognitive modality that may have been damaged because of an injury or a disease.
Market Dynamics and Trends
The global neuroprosthetics market is growing due to several factors, such as the rising number of patients suffering from neurological disorders and nerve injuries, the growing prevalence of diabetes, the increasing incidence of hearing loss, and technological advancements in the devices.
The rising advancements in neuroprosthetics and the growing need for neuroprosthetics are fueling global market growth.
The advancements and developments in neuroprosthetics are fueling market growth. For instance, DRG (Dorsal Root Ganglion) therapy by ABBOT helps in treating chronic pain associated with severe chronic intractable pain of the lower limbs in adult patients with complex regional pain syndrome (CRPS) types I and II post-amputation or both prosthetic implant; this therapy acts by using mild electrical signals to treat chronic pain. Furthermore, the RNS system developed by Neurospace is the only FDA-approved epilepsy device that provides personalized treatment by responding to abnormal brain activity and tracking EEG data which helps in improving patient care. Moreover, Boston Scientific is the first to engineer a neuroprosthetic called Vercise DBS for accurate neural targeting allowing personalized therapy for patients with Parkinson’s disease, primary and secondary dystonia, and essential tremor. In addition, the growing incidences of traumatic brain injuries and neurological diseases are fueling the global market growth; for instance, around 1 in 3 people have been affected by a neurological disease at some point in their life over the past 3 decades, and the neurological disorder deaths have increased by almost 40%; also, around 20-50 million people yearly suffer from non-fatal injuries road crashes majority of which suffer from some neurological damage.
The high cost will hamper the global market growth.
However, the high cost of the devices hinders the market’s growth. Neuroprosthetics is an emerging treatment option for hearing damage, which makes them very expensive, especially in developing countries. Neuroprosthetics such as cochlear, visual, and hippocampal (or cognition) prostheses are generally very expensive and make it difficult for most patients to access.
Industry analysis
The global neuroprosthetics market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, Etc.
COVID-19 Impact Analysis on Neuroprosthetics Market
The supply chain was disrupted during COVID-19, which caused a lack of raw materials in the market, putting global research and development projects on hold as most of the research institutes and universities were shut down. Moreover, regular healthcare check-ups were difficult amidst the pandemic, leaving most patients with undetected neurological disorders because of the travel and socializing restrictions; there was a reduction in road and traffic injuries reducing the cases of traumatic brain injury, and overall impacting the neuroprosthetics market.
Segmentation Analysis
The output neural prosthetics are predicted to dominate the global market during the forecast period (2024-2031).
The output neural prosthetics include cognitive prosthetics and cochlear implants. The output neural prosthetics accounted for the largest market share in 2021. The input neural prosthetics include bionic eye/retinal implants. Retinal implants are estimated to grow at the fastest growth rate during the forecast period, owing to the rising penetration and the increasing R&D efforts for product innovation. For instance, in the case of cochlear implants, millions of dollars are being spent every year to achieve even more powerful and effective hearing treatment options. These efforts include better preserving the neural structures in the inner ear through electrode design and bringing a more natural hearing experience through networking the devices worn on both ears. Furthermore, work on ways to improve the hearing experience through the argumentation of artificial intelligence and the introduction of new signal processing algorithms, as well as to develop app-based remote controls.
Geographical Share
North America is estimated to subjugate the global Neuroprosthetics market.
The North American region holds the major part of the global Neuroprosthetics Since there are high incidences of traumatic brain injuries, a growing geriatric population, and increasing R&D investments. For instance, according to the CDC data, around 64,362 deaths in 2020 were claimed by traumatic brain injury, making up 611 hospitalizations and 176 deaths daily to traumatic brain injury as the cause. These statistics CDC provided exclude the traumatic brain injuries treated in emergency departments, primary care, urgent care or untreated ones. Patients aged 75 and older were the ones that accounted for the highest number and rates of traumatic brain injuries. Therefore, the growing geriatric population in North America is also a contributing factor to North America's command over the global market. For instance, according to statistics from The Population Reference Bureau, over 55 million Americans are 65 or older, per the estimate from the Census Bureau's 2020 population. In addition, increasing R&D investments, growing funding from government and private institutes, and the large presence of neural implant manufacturers drive market growth in this region. For instance, the Defense Advanced Research Project Agency (DARPA) and National Institute of Neurological Disorders and Stroke (NIH), in collaboration with federal agencies, are instrumental in providing funds to support R&D initiatives for the further development of neural implants.
Companies and Competitive Landscape
The neuroprosthetics market is competitive, with few major players competing to gain market share. Some major players in the global neuroprosthetics market include Boston Scientific, Medtronic, Abbott, Cochlear, LivaNova, Sonova, Retina Implant, Med-El, Neuropace, and NDI Medical, among others. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations contributing to the growth of the neuroprosthetics market globally. For instance, AUG 31, 2022, Medtronic partnered with BioIntelliSense for exclusive U.S. distribution of multi-parameter wearables for continuous remote patient monitoring from in-hospital to home. Also, AUG 30, 2022, Medtronic acquired Affera.
Medtronic, Plc.
Overview:
Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.
Product Portfolio:
Medtronic plc’s product portfolio for neuroprosthetics has Percept PC DBS System, Activa RC system, SenSight Directional Leads, VANTA PC Neurostimulator, INTELLIS Neurostimulator, Primeadvanced Surescan MRI Neurostimulator, and Restore.
The global neuroprosthetics market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.
Neuroprosthetics Market is estimated to reach at a CAGR of 12.2% during the forecast period (2024-2031). Neuroprosthetics (neural prosthetics) is a branch of neuroscience and biomedical engineering concerned with developing neural prostheses. These are a series of devices that can substitute for the functions of a motor, sensory, or cognitive modality that may have been damaged because of an injury or a disease.
Market Dynamics and Trends
The global neuroprosthetics market is growing due to several factors, such as the rising number of patients suffering from neurological disorders and nerve injuries, the growing prevalence of diabetes, the increasing incidence of hearing loss, and technological advancements in the devices.
The rising advancements in neuroprosthetics and the growing need for neuroprosthetics are fueling global market growth.
The advancements and developments in neuroprosthetics are fueling market growth. For instance, DRG (Dorsal Root Ganglion) therapy by ABBOT helps in treating chronic pain associated with severe chronic intractable pain of the lower limbs in adult patients with complex regional pain syndrome (CRPS) types I and II post-amputation or both prosthetic implant; this therapy acts by using mild electrical signals to treat chronic pain. Furthermore, the RNS system developed by Neurospace is the only FDA-approved epilepsy device that provides personalized treatment by responding to abnormal brain activity and tracking EEG data which helps in improving patient care. Moreover, Boston Scientific is the first to engineer a neuroprosthetic called Vercise DBS for accurate neural targeting allowing personalized therapy for patients with Parkinson’s disease, primary and secondary dystonia, and essential tremor. In addition, the growing incidences of traumatic brain injuries and neurological diseases are fueling the global market growth; for instance, around 1 in 3 people have been affected by a neurological disease at some point in their life over the past 3 decades, and the neurological disorder deaths have increased by almost 40%; also, around 20-50 million people yearly suffer from non-fatal injuries road crashes majority of which suffer from some neurological damage.
The high cost will hamper the global market growth.
However, the high cost of the devices hinders the market’s growth. Neuroprosthetics is an emerging treatment option for hearing damage, which makes them very expensive, especially in developing countries. Neuroprosthetics such as cochlear, visual, and hippocampal (or cognition) prostheses are generally very expensive and make it difficult for most patients to access.
Industry analysis
The global neuroprosthetics market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, Etc.
COVID-19 Impact Analysis on Neuroprosthetics Market
The supply chain was disrupted during COVID-19, which caused a lack of raw materials in the market, putting global research and development projects on hold as most of the research institutes and universities were shut down. Moreover, regular healthcare check-ups were difficult amidst the pandemic, leaving most patients with undetected neurological disorders because of the travel and socializing restrictions; there was a reduction in road and traffic injuries reducing the cases of traumatic brain injury, and overall impacting the neuroprosthetics market.
Segmentation Analysis
The output neural prosthetics are predicted to dominate the global market during the forecast period (2024-2031).
The output neural prosthetics include cognitive prosthetics and cochlear implants. The output neural prosthetics accounted for the largest market share in 2021. The input neural prosthetics include bionic eye/retinal implants. Retinal implants are estimated to grow at the fastest growth rate during the forecast period, owing to the rising penetration and the increasing R&D efforts for product innovation. For instance, in the case of cochlear implants, millions of dollars are being spent every year to achieve even more powerful and effective hearing treatment options. These efforts include better preserving the neural structures in the inner ear through electrode design and bringing a more natural hearing experience through networking the devices worn on both ears. Furthermore, work on ways to improve the hearing experience through the argumentation of artificial intelligence and the introduction of new signal processing algorithms, as well as to develop app-based remote controls.
Geographical Share
North America is estimated to subjugate the global Neuroprosthetics market.
The North American region holds the major part of the global Neuroprosthetics Since there are high incidences of traumatic brain injuries, a growing geriatric population, and increasing R&D investments. For instance, according to the CDC data, around 64,362 deaths in 2020 were claimed by traumatic brain injury, making up 611 hospitalizations and 176 deaths daily to traumatic brain injury as the cause. These statistics CDC provided exclude the traumatic brain injuries treated in emergency departments, primary care, urgent care or untreated ones. Patients aged 75 and older were the ones that accounted for the highest number and rates of traumatic brain injuries. Therefore, the growing geriatric population in North America is also a contributing factor to North America's command over the global market. For instance, according to statistics from The Population Reference Bureau, over 55 million Americans are 65 or older, per the estimate from the Census Bureau's 2020 population. In addition, increasing R&D investments, growing funding from government and private institutes, and the large presence of neural implant manufacturers drive market growth in this region. For instance, the Defense Advanced Research Project Agency (DARPA) and National Institute of Neurological Disorders and Stroke (NIH), in collaboration with federal agencies, are instrumental in providing funds to support R&D initiatives for the further development of neural implants.
Companies and Competitive Landscape
The neuroprosthetics market is competitive, with few major players competing to gain market share. Some major players in the global neuroprosthetics market include Boston Scientific, Medtronic, Abbott, Cochlear, LivaNova, Sonova, Retina Implant, Med-El, Neuropace, and NDI Medical, among others. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations contributing to the growth of the neuroprosthetics market globally. For instance, AUG 31, 2022, Medtronic partnered with BioIntelliSense for exclusive U.S. distribution of multi-parameter wearables for continuous remote patient monitoring from in-hospital to home. Also, AUG 30, 2022, Medtronic acquired Affera.
Medtronic, Plc.
Overview:
Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.
Product Portfolio:
Medtronic plc’s product portfolio for neuroprosthetics has Percept PC DBS System, Activa RC system, SenSight Directional Leads, VANTA PC Neurostimulator, INTELLIS Neurostimulator, Primeadvanced Surescan MRI Neurostimulator, and Restore.
The global neuroprosthetics market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Innovations and Developments
4.1.1.2. The Growing Need For Neuroprosthetics
4.1.2. Restraints
4.1.2.1. High Cost
4.1.2.2. Lack of Skilled Professionals
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
7.1.2. Market Attractiveness Index, By Type Segment
7.2. Output Neural Prosthetics
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.2.3. Motor Prosthetics
7.2.4. Cognitive Prosthetics
7.3. Input Neural Prosthetics
7.3.1. Cochlear Implants
7.3.2. BImplants/Retinal Implants
8. BY TECHNOLOGY
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
8.1.2. Market Attractiveness Index, By Technology Segment
8.2. Spinal Cord Stimulation
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.3. Deep Brain Stimulation
8.4. Vagus Nerve Stimulation
8.5. Transcranial magnetic Stimulation
8.6. Sacral Nerve Stimulation
8.7. Others
9. BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
9.1.2. Market Attractiveness Index, By Application Segment
9.2. Physiological Disorders
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
9.2.3. Auditory Processing Disorders
9.2.4. Ophthalmic Disorders
9.2.5. Cardiovascular Disorders
9.2.6. Urology Disorder
9.3. Motor Neuron Disorders
9.3.1. Parkinson’s Disease
9.3.2. Epilepsy
9.4. Cognitive Disorders Specialized
9.4.1. Alzheimer’s Disease
9.4.2. Paralysis
10. BY END USER
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
10.1.2. Market Attractiveness Index, By End User Segment
10.2. Hospitals
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
10.3. Specialized Neurosurgery Centers
10.4. Others
11. BY REGION
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. The U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. The U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12. COMPETITIVE LANDSCAPE
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking
13. COMPANY PROFILES
13.1. Medtronic Plc
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Boston Scientific
13.3. Abbott
13.4. Cochlear
13.5. LivaNova
13.6. Sonova
13.7. Retina Implant
13.8. Med-El
13.9. Neuropace
13.10. NDI Medical(*LIST NOT EXHAUSTIVE)
14. DATAM INTELLIGENCE
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Innovations and Developments
4.1.1.2. The Growing Need For Neuroprosthetics
4.1.2. Restraints
4.1.2.1. High Cost
4.1.2.2. Lack of Skilled Professionals
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
7.1.2. Market Attractiveness Index, By Type Segment
7.2. Output Neural Prosthetics
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.2.3. Motor Prosthetics
7.2.4. Cognitive Prosthetics
7.3. Input Neural Prosthetics
7.3.1. Cochlear Implants
7.3.2. BImplants/Retinal Implants
8. BY TECHNOLOGY
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
8.1.2. Market Attractiveness Index, By Technology Segment
8.2. Spinal Cord Stimulation
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.3. Deep Brain Stimulation
8.4. Vagus Nerve Stimulation
8.5. Transcranial magnetic Stimulation
8.6. Sacral Nerve Stimulation
8.7. Others
9. BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
9.1.2. Market Attractiveness Index, By Application Segment
9.2. Physiological Disorders
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
9.2.3. Auditory Processing Disorders
9.2.4. Ophthalmic Disorders
9.2.5. Cardiovascular Disorders
9.2.6. Urology Disorder
9.3. Motor Neuron Disorders
9.3.1. Parkinson’s Disease
9.3.2. Epilepsy
9.4. Cognitive Disorders Specialized
9.4.1. Alzheimer’s Disease
9.4.2. Paralysis
10. BY END USER
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
10.1.2. Market Attractiveness Index, By End User Segment
10.2. Hospitals
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
10.3. Specialized Neurosurgery Centers
10.4. Others
11. BY REGION
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. The U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. The U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12. COMPETITIVE LANDSCAPE
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking
13. COMPANY PROFILES
13.1. Medtronic Plc
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Boston Scientific
13.3. Abbott
13.4. Cochlear
13.5. LivaNova
13.6. Sonova
13.7. Retina Implant
13.8. Med-El
13.9. Neuropace
13.10. NDI Medical(*LIST NOT EXHAUSTIVE)
14. DATAM INTELLIGENCE
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us
LIST OF TABLES
Table No 1 Global Neuroprosthetics Market Value, By Type, 2022, 2026 & 2030 ($ Million)
Table No 2 Global Neuroprosthetics Market Value, By Technology, 2022, 2026 & 2030 ($ Million)
Table No 3 Global Neuroprosthetics Market Value, By Application, 2022, 2026 & 2030 ($ Million)
Table No 4 Global Neuroprosthetics Market Value, By End User, 2022, 2026 & 2030 ($ Million)
Table No 5 Global Neuroprosthetics Market Value, By Region, 2022, 2026 & 2030 ($ Million)
Table No 6 Global Neuroprosthetics Market Value, By Type, 2022, 2026 & 2030 ($ Million)
Table No 7 Global Neuroprosthetics Market Value, By Type, 2022-2030 ($ Million)
Table No 8 Global Neuroprosthetics Market Value, By Technology, 2022, 2026 & 2030 ($ Million)
Table No 9 Global Neuroprosthetics Market Value, By Technology, 2022-2030 ($ Million)
Table No 10 Global Neuroprosthetics Market Value, By Application, 2022, 2026 & 2030 ($ Million)
Table No 11 Global Neuroprosthetics Market Value, By Application, 2022-2030 ($ Million)
Table No 12 Global Neuroprosthetics Market Value, By End User, 2022, 2026 & 2030 ($ Million)
Table No 13 Global Neuroprosthetics Market Value, By End User, 2022-2030 ($ Million)
Table No 14 Global Neuroprosthetics Market Value, By Region, 2022, 2026 & 2030 ($ Million)
Table No 15 Global Neuroprosthetics Market Value, By Region, 2022-2030 ($ Million)
Table No 16 North America Neuroprosthetics Market Value, By Type, 2022-2030 ($ Million)
Table No 17 North America Neuroprosthetics Market Value, By Technology, 2022-2030 ($ Million)
Table No 18 North America Neuroprosthetics Market Value, By Application, 2022-2030 ($ Million)
Table No 19 North America Neuroprosthetics Market Value, By End User, 2022-2030 ($ Million)
Table No 20 North America Neuroprosthetics Market Value, By Country, 2022-2030 ($ Million)
Table No 21 South America Neuroprosthetics Market Value, By Type, 2022-2030 ($ Million)
Table No 22 South America Neuroprosthetics Market Value, By Technology, 2022-2030 ($ Million)
Table No 23 South America Neuroprosthetics Market Value, By Application, 2022-2030 ($ Million)
Table No 24 South America Neuroprosthetics Market Value, By End User, 2022-2030 ($ Million)
Table No 25 South America Neuroprosthetics Market Value, By Country, 2022-2030 ($ Million)
Table No 26 Europe Neuroprosthetics Market Value, By Type, 2022-2030 ($ Million)
Table No 27 Europe Neuroprosthetics Market Value, By Technology, 2022-2030 ($ Million)
Table No 28 Europe Neuroprosthetics Market Value, By Application, 2022-2030 ($ Million)
Table No 29 Europe Neuroprosthetics Market Value, By End User, 2022-2030 ($ Million)
Table No 30 Europe Neuroprosthetics Market Value, By Country, 2022-2030 ($ Million)
Table No 31 Asia-Pacific Neuroprosthetics Market Value, By Type, 2022-2030 ($ Million)
Table No 32 Asia-Pacific Neuroprosthetics Market Value, By Technology, 2022-2030 ($ Million)
Table No 33 Asia-Pacific Neuroprosthetics Market Value, By Application, 2022-2030 ($ Million)
Table No 34 Asia-Pacific Neuroprosthetics Market Value, By End User, 2022-2030 ($ Million)
Table No 35 Asia-Pacific Neuroprosthetics Market Value, By Country, 2022-2030 ($ Million)
Table No 36 Middle East & Africa Neuroprosthetics Market Value, By Type, 2022-2030 ($ Million)
Table No 37 Middle East & Africa Neuroprosthetics Market Value, By Technology, 2022-2030 ($ Million)
Table No 38 Middle East & Africa Neuroprosthetics Market Value, By Application, 2022-2030 ($ Million)
Table No 39 Middle East & Africa Neuroprosthetics Market Value, By End User, 2022-2030 ($ Million)
Table No 40 Medtronic Plc: Overview
Table No 41 Medtronic Plc: Product Portfolio
Table No 42 Medtronic Plc: Key Developments
Table No 43 Boston Scientific: Overview
Table No 44 Boston Scientific: Product Portfolio
Table No 45 Boston Scientific: Key Developments
Table No 46 Abbott: Overview
Table No 47 Abbott: Product Portfolio
Table No 48 Abbott: Key Developments
Table No 49 Cochlear: Overview
Table No 50 Cochlear: Product Portfolio
Table No 51 Cochlear: Key Developments
Table No 52 LivaNova: Overview
Table No 53 LivaNova: Product Portfolio
Table No 54 LivaNova: Key Developments
Table No 55 Sonova: Overview
Table No 56 Sonova: Product Portfolio
Table No 57 Sonova: Key Developments
Table No 58 Retina Implant: Overview
Table No 59 Retina Implant: Product Portfolio
Table No 60 Retina Implant: Key Developments
Table No 61 Med-El: Overview
Table No 62 Med-El: Product Portfolio
Table No 63 Med-El: Key Developments
Table No 64 Neuropace: Overview
Table No 65 Neuropace: Product Portfolio
Table No 66 Neuropace: Key Developments
Table No 67 NDI Medical: Overview
Table No 68 NDI Medical: Product Portfolio
Table No 69 NDI Medical: Key Developments
Table No 1 Global Neuroprosthetics Market Value, By Type, 2022, 2026 & 2030 ($ Million)
Table No 2 Global Neuroprosthetics Market Value, By Technology, 2022, 2026 & 2030 ($ Million)
Table No 3 Global Neuroprosthetics Market Value, By Application, 2022, 2026 & 2030 ($ Million)
Table No 4 Global Neuroprosthetics Market Value, By End User, 2022, 2026 & 2030 ($ Million)
Table No 5 Global Neuroprosthetics Market Value, By Region, 2022, 2026 & 2030 ($ Million)
Table No 6 Global Neuroprosthetics Market Value, By Type, 2022, 2026 & 2030 ($ Million)
Table No 7 Global Neuroprosthetics Market Value, By Type, 2022-2030 ($ Million)
Table No 8 Global Neuroprosthetics Market Value, By Technology, 2022, 2026 & 2030 ($ Million)
Table No 9 Global Neuroprosthetics Market Value, By Technology, 2022-2030 ($ Million)
Table No 10 Global Neuroprosthetics Market Value, By Application, 2022, 2026 & 2030 ($ Million)
Table No 11 Global Neuroprosthetics Market Value, By Application, 2022-2030 ($ Million)
Table No 12 Global Neuroprosthetics Market Value, By End User, 2022, 2026 & 2030 ($ Million)
Table No 13 Global Neuroprosthetics Market Value, By End User, 2022-2030 ($ Million)
Table No 14 Global Neuroprosthetics Market Value, By Region, 2022, 2026 & 2030 ($ Million)
Table No 15 Global Neuroprosthetics Market Value, By Region, 2022-2030 ($ Million)
Table No 16 North America Neuroprosthetics Market Value, By Type, 2022-2030 ($ Million)
Table No 17 North America Neuroprosthetics Market Value, By Technology, 2022-2030 ($ Million)
Table No 18 North America Neuroprosthetics Market Value, By Application, 2022-2030 ($ Million)
Table No 19 North America Neuroprosthetics Market Value, By End User, 2022-2030 ($ Million)
Table No 20 North America Neuroprosthetics Market Value, By Country, 2022-2030 ($ Million)
Table No 21 South America Neuroprosthetics Market Value, By Type, 2022-2030 ($ Million)
Table No 22 South America Neuroprosthetics Market Value, By Technology, 2022-2030 ($ Million)
Table No 23 South America Neuroprosthetics Market Value, By Application, 2022-2030 ($ Million)
Table No 24 South America Neuroprosthetics Market Value, By End User, 2022-2030 ($ Million)
Table No 25 South America Neuroprosthetics Market Value, By Country, 2022-2030 ($ Million)
Table No 26 Europe Neuroprosthetics Market Value, By Type, 2022-2030 ($ Million)
Table No 27 Europe Neuroprosthetics Market Value, By Technology, 2022-2030 ($ Million)
Table No 28 Europe Neuroprosthetics Market Value, By Application, 2022-2030 ($ Million)
Table No 29 Europe Neuroprosthetics Market Value, By End User, 2022-2030 ($ Million)
Table No 30 Europe Neuroprosthetics Market Value, By Country, 2022-2030 ($ Million)
Table No 31 Asia-Pacific Neuroprosthetics Market Value, By Type, 2022-2030 ($ Million)
Table No 32 Asia-Pacific Neuroprosthetics Market Value, By Technology, 2022-2030 ($ Million)
Table No 33 Asia-Pacific Neuroprosthetics Market Value, By Application, 2022-2030 ($ Million)
Table No 34 Asia-Pacific Neuroprosthetics Market Value, By End User, 2022-2030 ($ Million)
Table No 35 Asia-Pacific Neuroprosthetics Market Value, By Country, 2022-2030 ($ Million)
Table No 36 Middle East & Africa Neuroprosthetics Market Value, By Type, 2022-2030 ($ Million)
Table No 37 Middle East & Africa Neuroprosthetics Market Value, By Technology, 2022-2030 ($ Million)
Table No 38 Middle East & Africa Neuroprosthetics Market Value, By Application, 2022-2030 ($ Million)
Table No 39 Middle East & Africa Neuroprosthetics Market Value, By End User, 2022-2030 ($ Million)
Table No 40 Medtronic Plc: Overview
Table No 41 Medtronic Plc: Product Portfolio
Table No 42 Medtronic Plc: Key Developments
Table No 43 Boston Scientific: Overview
Table No 44 Boston Scientific: Product Portfolio
Table No 45 Boston Scientific: Key Developments
Table No 46 Abbott: Overview
Table No 47 Abbott: Product Portfolio
Table No 48 Abbott: Key Developments
Table No 49 Cochlear: Overview
Table No 50 Cochlear: Product Portfolio
Table No 51 Cochlear: Key Developments
Table No 52 LivaNova: Overview
Table No 53 LivaNova: Product Portfolio
Table No 54 LivaNova: Key Developments
Table No 55 Sonova: Overview
Table No 56 Sonova: Product Portfolio
Table No 57 Sonova: Key Developments
Table No 58 Retina Implant: Overview
Table No 59 Retina Implant: Product Portfolio
Table No 60 Retina Implant: Key Developments
Table No 61 Med-El: Overview
Table No 62 Med-El: Product Portfolio
Table No 63 Med-El: Key Developments
Table No 64 Neuropace: Overview
Table No 65 Neuropace: Product Portfolio
Table No 66 Neuropace: Key Developments
Table No 67 NDI Medical: Overview
Table No 68 NDI Medical: Product Portfolio
Table No 69 NDI Medical: Key Developments
LIST OF FIGURES
Figure No 1 Global Neuroprosthetics Market Share, By Type, 2022 & 2030 (%)
Figure No 2 Global Neuroprosthetics Market Share, By Technology, 2022 & 2030 (%)
Figure No 3 Global Neuroprosthetics Market Share, By Application, 2022 & 2030 (%)
Figure No 4 Global Neuroprosthetics Market Share, By End User, 2022 & 2030 (%)
Figure No 5 Global Neuroprosthetics Market Share, By Region, 2022 & 2030 (%)
Figure No 6 Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 7 Global Neuroprosthetics Market Y-o-Y Growth, By Type, 2021-2029 (%)
Figure No 8 Output Neural Prosthetics: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 9 Input Neural Prosthetics: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 10 Global Neuroprosthetics Market Y-o-Y Growth, By Technology, 2021-2029 (%)
Figure No 11 Spinal Cord Stimulation: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 12 Deep Brain Stimulation: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 13 Vagus Nerve Stimulation: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 14 Transcranial magnetic Stimulation: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 15 Sacral Nerve Stimulation: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 16 Others: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 17 Global Neuroprosthetics Market Y-o-Y Growth, By Application, 2021-2029 (%)
Figure No 18 Physiological Disorders: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 19 Motor Neuron Disorders: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 20 Cognitive Disorders Specialized: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 21 Global Neuroprosthetics Market Y-o-Y Growth, By End User, 2021-2029 (%)
Figure No 22 Hospitals: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 23 Specialized Neurosurgery Centers: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 24 Others: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 25 Global Neuroprosthetics Market Y-o-Y Growth, By Region, 2021-2029 (%)
Figure No 26 North America Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 27 North America Neuroprosthetics Market Share, By Type, 2022 & 2030 (%)
Figure No 28 North America Neuroprosthetics Market Share, By Technology, 2022 & 2030 (%)
Figure No 29 North America Neuroprosthetics Market Share, By Application, 2022 & 2030 (%)
Figure No 30 North America Neuroprosthetics Market Share, By End User, 2022 & 2030 (%)
Figure No 31 North America Neuroprosthetics Market Share, By Country, 2022 & 2030 (%)
Figure No 32 South America Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 33 South America Neuroprosthetics Market Share, By Type, 2022 & 2030 (%)
Figure No 34 South America Neuroprosthetics Market Share, By Technology, 2022 & 2030 (%)
Figure No 35 South America Neuroprosthetics Market Share, By Application, 2022 & 2030 (%)
Figure No 36 South America Neuroprosthetics Market Share, By End User, 2022 & 2030 (%)
Figure No 37 South America Neuroprosthetics Market Share, By Country, 2022 & 2030 (%)
Figure No 38 Europe Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 39 Europe Neuroprosthetics Market Share, By Type, 2022 & 2030 (%)
Figure No 40 Europe Neuroprosthetics Market Share, By Technology, 2022 & 2030 (%)
Figure No 41 Europe Neuroprosthetics Market Share, By Application, 2022 & 2030 (%)
Figure No 42 Europe Neuroprosthetics Market Share, By End User, 2022 & 2030 (%)
Figure No 43 Europe Neuroprosthetics Market Share, By Country, 2022 & 2030 (%)
Figure No 44 Asia-Pacific Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 45 Asia-Pacific Neuroprosthetics Market Share, By Type, 2022 & 2030 (%)
Figure No 46 Asia-Pacific Neuroprosthetics Market Share, By Technology, 2022 & 2030 (%)
Figure No 47 Asia-Pacific Neuroprosthetics Market Share, By Application, 2022 & 2030 (%)
Figure No 48 Asia-Pacific Neuroprosthetics Market Share, By End User, 2022 & 2030 (%)
Figure No 49 Asia-Pacific Neuroprosthetics Market Share, By Country, 2022 & 2030 (%)
Figure No 50 Middle East & Africa Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 51 Middle East & Africa Neuroprosthetics Market Share, By Type, 2022 & 2030 (%)
Figure No 52 Middle East & Africa Neuroprosthetics Market Share, By Technology, 2022 & 2030 (%)
Figure No 53 Middle East & Africa Neuroprosthetics Market Share, By Application, 2022 & 2030 (%)
Figure No 54 Middle East & Africa Neuroprosthetics Market Share, By End User, 2022 & 2030 (%)
Figure No 55 Medtronic Plc: Financials
Figure No 56 Boston Scientific: Financials
Figure No 57 Abbott: Financials
Figure No 58 Cochlear: Financials
Figure No 59 LivaNova: Financials
Figure No 60 Sonova: Financials
Figure No 61 Retina Implant: Financials
Figure No 62 Med-El: Financials
Figure No 63 Neuropace: Financials
Figure No 64 NDI Medical: Financials
Figure No 1 Global Neuroprosthetics Market Share, By Type, 2022 & 2030 (%)
Figure No 2 Global Neuroprosthetics Market Share, By Technology, 2022 & 2030 (%)
Figure No 3 Global Neuroprosthetics Market Share, By Application, 2022 & 2030 (%)
Figure No 4 Global Neuroprosthetics Market Share, By End User, 2022 & 2030 (%)
Figure No 5 Global Neuroprosthetics Market Share, By Region, 2022 & 2030 (%)
Figure No 6 Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 7 Global Neuroprosthetics Market Y-o-Y Growth, By Type, 2021-2029 (%)
Figure No 8 Output Neural Prosthetics: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 9 Input Neural Prosthetics: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 10 Global Neuroprosthetics Market Y-o-Y Growth, By Technology, 2021-2029 (%)
Figure No 11 Spinal Cord Stimulation: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 12 Deep Brain Stimulation: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 13 Vagus Nerve Stimulation: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 14 Transcranial magnetic Stimulation: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 15 Sacral Nerve Stimulation: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 16 Others: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 17 Global Neuroprosthetics Market Y-o-Y Growth, By Application, 2021-2029 (%)
Figure No 18 Physiological Disorders: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 19 Motor Neuron Disorders: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 20 Cognitive Disorders Specialized: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 21 Global Neuroprosthetics Market Y-o-Y Growth, By End User, 2021-2029 (%)
Figure No 22 Hospitals: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 23 Specialized Neurosurgery Centers: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 24 Others: Global Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 25 Global Neuroprosthetics Market Y-o-Y Growth, By Region, 2021-2029 (%)
Figure No 26 North America Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 27 North America Neuroprosthetics Market Share, By Type, 2022 & 2030 (%)
Figure No 28 North America Neuroprosthetics Market Share, By Technology, 2022 & 2030 (%)
Figure No 29 North America Neuroprosthetics Market Share, By Application, 2022 & 2030 (%)
Figure No 30 North America Neuroprosthetics Market Share, By End User, 2022 & 2030 (%)
Figure No 31 North America Neuroprosthetics Market Share, By Country, 2022 & 2030 (%)
Figure No 32 South America Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 33 South America Neuroprosthetics Market Share, By Type, 2022 & 2030 (%)
Figure No 34 South America Neuroprosthetics Market Share, By Technology, 2022 & 2030 (%)
Figure No 35 South America Neuroprosthetics Market Share, By Application, 2022 & 2030 (%)
Figure No 36 South America Neuroprosthetics Market Share, By End User, 2022 & 2030 (%)
Figure No 37 South America Neuroprosthetics Market Share, By Country, 2022 & 2030 (%)
Figure No 38 Europe Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 39 Europe Neuroprosthetics Market Share, By Type, 2022 & 2030 (%)
Figure No 40 Europe Neuroprosthetics Market Share, By Technology, 2022 & 2030 (%)
Figure No 41 Europe Neuroprosthetics Market Share, By Application, 2022 & 2030 (%)
Figure No 42 Europe Neuroprosthetics Market Share, By End User, 2022 & 2030 (%)
Figure No 43 Europe Neuroprosthetics Market Share, By Country, 2022 & 2030 (%)
Figure No 44 Asia-Pacific Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 45 Asia-Pacific Neuroprosthetics Market Share, By Type, 2022 & 2030 (%)
Figure No 46 Asia-Pacific Neuroprosthetics Market Share, By Technology, 2022 & 2030 (%)
Figure No 47 Asia-Pacific Neuroprosthetics Market Share, By Application, 2022 & 2030 (%)
Figure No 48 Asia-Pacific Neuroprosthetics Market Share, By End User, 2022 & 2030 (%)
Figure No 49 Asia-Pacific Neuroprosthetics Market Share, By Country, 2022 & 2030 (%)
Figure No 50 Middle East & Africa Neuroprosthetics Market Value, 2022-2030 ($ Million)
Figure No 51 Middle East & Africa Neuroprosthetics Market Share, By Type, 2022 & 2030 (%)
Figure No 52 Middle East & Africa Neuroprosthetics Market Share, By Technology, 2022 & 2030 (%)
Figure No 53 Middle East & Africa Neuroprosthetics Market Share, By Application, 2022 & 2030 (%)
Figure No 54 Middle East & Africa Neuroprosthetics Market Share, By End User, 2022 & 2030 (%)
Figure No 55 Medtronic Plc: Financials
Figure No 56 Boston Scientific: Financials
Figure No 57 Abbott: Financials
Figure No 58 Cochlear: Financials
Figure No 59 LivaNova: Financials
Figure No 60 Sonova: Financials
Figure No 61 Retina Implant: Financials
Figure No 62 Med-El: Financials
Figure No 63 Neuropace: Financials
Figure No 64 NDI Medical: Financials
